GlassScriptPhysician profile
Vedra A Augenstein
NPI 1962549527
$789,309.57
in general payments reported to CMS, 2019-2025
17 companies · $62K in 2025
The $62K reported for 2025 was more than what 99% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $276K · 2020: $47K · 2021: $120K · 2022: $148K · 2023: $62K · 2024: $75K · 2025: $62K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $102K · Consulting Fee: $78K · Travel and Lodging: $13K · Food and Beverage: $5,246.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $102,464.00 |
| Consulting Fee | $77,574.75 |
| Travel and Lodging | $13,215.62 |
| Food and Beverage | $5,245.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $429,687.73 | 2019-2022 | |
| Intuitive Surgical, INC. | $95,208.83 | 2019-2024 | |
| Abbvie INC. | $91,060.35 | 2022-2025 | Strattice Reconstructive Tissue Matrix Bps, Natrelle Saline-Filled Breast Implants, Revolve |
| Medtronic, INC. | $78,116.58 | 2021-2025 | Progrip, Absorbatack, Transorb |
| Pacira Pharmaceuticals Incorporated | $31,012.64 | 2023-2025 | Exparel, Zilretta, Iovera |
| Kci USA, INC. | $23,046.62 | 2019-2021 | |
| Covidien LP | $12,285.96 | 2019-2020 | |
| Davol INC. | $11,308.28 | 2020-2024 | Phasix Mesh |
| W. L. Gore & Associates, INC. | $10,524.68 | 2023 | Gore Synecor Biomaterial, Gore Enform Preperitoneal Biomaterial, Gore Bio-A Tissue Reinforcement |
| Integra Lifesciences Corporation | $3,250.00 | 2023 | Codman Certas, Surgimend |
| Convatec INC. | $3,000.00 | 2019 | |
| Conmed Corporation | $363.27 | 2019-2024 | Airseal |
| Polynovo North America LLC | $179.57 | 2025 | Novosorb Btm |
| Innocoll Pharmaceuticals Limited | $124.46 | 2022 | |
| Ethicon US, LLC | $78.51 | 2019-2024 | Vistaseal |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tela Bio, INC. | $31.39 | 2021 | |
| Janssen Pharmaceuticals, INC | $30.70 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vedra Augenstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.